Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Betterware México
BWMX
$617M
| $281K | ﹤0.01% |
43,700
-3,500
| -7% | -$24.9K |
|
3252
abrdn Physical Palladium Shares ETF
PALL
$653M
| $281K | ﹤0.01% |
8,500
-4,500
| -35% | -$162K |
|
3253
Fidelity MSCI Real Estate Index ETF
FREL
$1.49B
| $280K | ﹤0.01% |
11,300
-3,000
| -21% | -$74.2K |
|
3254
Radiant Logistics
RLGT
$409M
| $280K | ﹤0.01% |
+55,000
| New | +$308K |
|
|
WIMI
3255
WiMi Hologram Cloud
WIMI
$24.3M
| $280K | ﹤0.01% |
37,820
+8,320
| +28% | +$79.4K |
|
3256
V2X
VVX
$2.6B
| $279K | ﹤0.01% |
6,767
-17,533
| -72% | -$695K |
|
|
BBU
3257
DELISTED
Brookfield Business Partners
BBU
| $278K | ﹤0.01% |
16,431
-7,469
| -31% | -$145K |
|
3258
Forte Biosciences
FBRX
$1.57B
| $278K | ﹤0.01% |
11,100
-6,665
| -38% | -$171K |
|
3259
Solid Biosciences
SLDB
$975M
| $278K | ﹤0.01% |
51,763
-15,722
| -23% | -$103K |
|
|
ALIM
3260
DELISTED
Alimera Sciences
ALIM
| $278K | ﹤0.01% |
102,494
-10,200
| -9% | -$43.4K |
|
3261
Nuvation Bio
NUVB
$2.13B
| $277K | ﹤0.01% |
144,200
-116,315
| -45% | -$235K |
|
3262
FreightCar America
RAIL
$240M
| $277K | ﹤0.01% |
86,600
+10,765
| +14% | +$40.3K |
|
|
FRGE
3263
DELISTED
Forge Global Holdings
FRGE
| $275K | ﹤0.01% |
10,613
-21,279
| -67% | -$484K |
|
|
ICAD
3264
DELISTED
iCAD Inc
ICAD
| $275K | ﹤0.01% |
150,133
-61,557
| -29% | -$115K |
|
3265
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$638M
| $274K | ﹤0.01% |
5,800
-4,400
| -43% | -$241K |
|
3266
ProShares Ultra Energy
DIG
$85.8M
| $272K | ﹤0.01% |
+6,400
| New | +$275K |
|
3267
Heritage Global
HGBL
$37.5M
| $272K | ﹤0.01% |
115,917
+20,246
| +21% | +$42.3K |
|
|
INZY
3268
DELISTED
Inozyme Pharma
INZY
| $272K | ﹤0.01% |
258,900
+103,500
| +67% | +$181K |
|
|
MLNK
3269
DELISTED
MeridianLink
MLNK
| $272K | ﹤0.01% |
19,800
+5,700
| +40% | +$88K |
|
3270
Invesco CEF Income Composite ETF
PCEF
$821M
| $272K | ﹤0.01% |
+14,988
| New | +$274K |
|
|
CEPU
3271
Central Puerto
CEPU
$1.96B
| $271K | ﹤0.01% |
45,700
+7,750
| +20% | +$38.1K |
|
3272
Ceragon Networks
CRNT
$199M
| $270K | ﹤0.01% |
141,263
+58,063
| +70% | +$109K |
|
|
LTC
3273
LTC Properties
LTC
$2.19B
| $270K | ﹤0.01% |
+7,600
| New | +$289K |
|
|
PETQ
3274
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $270K | ﹤0.01% |
29,268
-24,632
| -46% | -$230K |
|
3275
Katapult Holdings
KPLT
$35.9M
| $269K | ﹤0.01% |
11,248
+884
| +9% | +$21.1K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.